Table 2

 Characteristics of 1109 patients with rheumatoid arthritis according to their DAS28 scores

Clinical featureDAS28
<3.23.2 to 5.1>5.1p Value
2 test.
**Analysis of variance.
DAS28, 28 joint disease activity score; HAQ, health assessment questionnaire.
Number of patients (%)199 (100)414 (100)352 (100)
Age (years) (mean (SD))56.7 (13.8)56.6 (14.2)56.6 (13.4)NS**
Female (%)129 (65.8)328 (79.6)279 (80.9)<0.001*
Disease duration (months) (mean (SD))108.8 (92.8)128.0 (114.9)131.1 (110.4)0.057**
Rheumatoid factor positive (%)65.373.979.8<0.001*
Presence of radiological lesions (%)64.379.581.0<0.001*
HAQ (mean (SD))0.7 (0.7)1.3 (0.7)1.7 (0.7)<0.001**
Number of hospital stays during the past 12 months (mean (SD))2.1 (2.1)2.4 (2.1)2.6 (2.1)NS**
Length of stay (days) (mean (SD))8.7 (10.8)12.7 (16.5)27.1 (23.0)0.002**
Per cent of patients with methotrexate during the past four weeks41.250.539.80.006*
Per cent of patients with methotrexate at any time during the disease63.378.380.1<0.001*